Summary
- Current Price
- As of today, UTHR price is $487.61, down -0.54% on
- Current Price All-Time High
- UTHR price is currently -19.98% below its historical high of $609.35 set on
- Market Cap
- UTHR current market cap is $21B, up +21.57% over the past 365 days
- PE Ratio
- UTHR current PE ratio is 17.44
- Revenue
- UTHR current annual revenue is $3.18B, up +10.61% year-over-year
- Next Earnings
- The next earnings release for UTHR is on
Profile
| Metric | Value |
|---|---|
| Full Name | United Therapeutics Corporation |
| Ticker | NASDAQ: UTHR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | unither.com |
| Employees | 1,305 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $487.61 | |
| Price, 1D Change | -0.54% | |
| Market Cap | $21B | |
| - | ||
| PE Ratio | 17.44 | |
| Beta | 0.26 | |
| Revenue | $3.18B | |
| Revenue, 1Y Change | +10.61% | |
| EPS | $27.86 | |
| EPS, 1Y Change | +13.08% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $27.86 | |
| EPS Estimate | $26.04 | N/A |
| EPS Est. Change | -6.54% | N/A |
| Revenue | $3.18B | |
| Revenue Estimate | $3.14B | N/A |
| Revenue Est. Change | -1.36% | N/A |
| Current Price | $487.61 | |
| Price Target | $685.00 | - |
| Price Tgt. Change | +40.48% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $24.57 | $24.64 | +0.30% | |
| $26.95 | $27.86 | +3.41% | |
| $26.04 | N/A | -6.54% | |
| $28.69 | N/A | +2.97% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.88B | $2.88B | +0.08% | |
| $3.20B | $3.18B | -0.55% | |
| $3.14B | N/A | -1.36% | |
| $3.44B | N/A | +8.14% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +28.16% | |
| Price, 3Y | +113.82% | |
| Market Cap, 1Y | +21.57% | |
| Market Cap, 3Y | +95.48% | |
| Revenue, 1Y | +10.61% | |
| Revenue, 3Y | +64.37% | |
| EPS, 1Y | +13.08% | |
| EPS, 3Y | +85.81% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $487.61 | |
| SMA 200 | $523.45 | |
| SMA 50 | $525.68 | |
| EMA 200 | $507.58 | |
| EMA 50 | $522.84 | |
| MACD | -$7.96 | |
| Beta | 0.26 | |
| ATR | $14.22 | |
| 14-Day RSI | 34.60 | |
| 10-Day Volatility | 27.49% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $3.18B | |
| EPS | $27.86 | |
| Gross Profit | $0.00 | |
| Gross Margin | 87.92% | |
| Operating Income | $1.52B | |
| Operating Margin | 47.67% | |
| Net Income | $1.33B | |
| Net Margin | 41.94% | |
| EBITDA | $1.60B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.00 | |
| 6.60 | ||
| 6.28 | ||
| - | ||
| 6 | ||
| 17.38 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | 17.44 | |
| 6.63 | ||
| 3.27 | ||
| 12.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $7.10B | |
| $2.92B | ||
| $7.97B | ||
| $3.70B | ||
| $872.90M | ||
| $560.60M | ||
| Total Debt | $0.00 | |
| $0.00 | ||
| $7.10M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.85B | ||
| $1.28B | ||
| $384.40M | ||
| $0.00 | ||
| $85.60M | ||
| $0.00 | ||
| $379.20M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $1.56B | ||
| -$551.30M | ||
| -$1.15B | ||
| Capex | $526.00M | |
| $1.04B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| JP Morgan | → | |
| B of A Securities | → | |
| RBC Capital | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → |
Analyst sentiment
Institutional ownership
Screeners with UTHR
FAQ
- What is the ticker symbol for United Therapeutics Corporation?
- The ticker symbol for United Therapeutics Corporation is NASDAQ:UTHR
- Does United Therapeutics Corporation pay dividends?
- No, United Therapeutics Corporation does not pay dividends
- What sector is United Therapeutics Corporation in?
- United Therapeutics Corporation is in the Healthcare sector
- What industry is United Therapeutics Corporation in?
- United Therapeutics Corporation is in the Specialty & Generic Drug Manufacturers industry
- What country is United Therapeutics Corporation based in?
- United Therapeutics Corporation is headquartered in United States
- When did United Therapeutics Corporation go public?
- United Therapeutics Corporation initial public offering (IPO) was on June 17, 1999
- Is United Therapeutics Corporation in the S&P 500?
- No, United Therapeutics Corporation is not included in the S&P 500 index
- Is United Therapeutics Corporation in the NASDAQ 100?
- No, United Therapeutics Corporation is not included in the NASDAQ 100 index
- Is United Therapeutics Corporation in the Dow Jones?
- No, United Therapeutics Corporation is not included in the Dow Jones index
- When was United Therapeutics Corporation last earnings report?
- United Therapeutics Corporation's most recent earnings report was on August 5, 2026
- When does United Therapeutics Corporation report earnings?
- The next expected earnings date for United Therapeutics Corporation is October 28, 2026
Data Sources & References
- UTHR Official Website www.unither.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1082554/000108255426000006/0001082554-26-000006-index.htm
- UTHR Profile on Yahoo Finance finance.yahoo.com/quote/UTHR
- UTHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uthr